Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis.
about
Preclinical rheumatoid arthritis (autoantibodies): an updated reviewProtein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with DysregulationPathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLEThe development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) iPredictive value of autoantibody testing for validating self-reported diagnoses of rheumatoid arthritis in the Women's Health Initiative.When and where does inflammation begin in rheumatoid arthritis?Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritisHigh throughput proteomic analysis of the secretome in an explant model of articular cartilage inflammationDescription and utilization of the United States department of defense serum repository: a review of published studies, 1985-2012.Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis.Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control studyStrategies to predict rheumatoid arthritis development in at-risk populations.Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin trapsA prospective cohort study of 14-3-3η in ACPA and/or RF-positive patients with arthralgiaThe next big idea.Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivityAssociation of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans.Can rheumatoid arthritis be prevented?Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American Populations.Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis.The pathogenic potential of autoreactive antibodies in rheumatoid arthritis.Epigenetic-based immune intervention for rheumatic diseases.PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis.The Complex Role of the Lung in the Pathogenesis and Clinical Outcomes of Rheumatoid Arthritis.The preclinical phase of rheumatoid arthritis: what is acknowledged and what needs to be assessed?Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types.Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis.Meta-analysis: diagnostic accuracy of antibody against peptidylarginine deiminase 4 by ELISA for rheumatoid arthritis.Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.Immunologic derangement preceding clinical autoimmunity.
P2860
Q26863441-5DA21848-0AC4-48CE-B392-9A74EE17846DQ27001595-53924961-7098-4381-A06A-0A8B0559321AQ27003201-2857DFE2-C783-4013-9869-A94C846F8277Q27672732-BCC3EC7F-6365-42B1-BAE3-BD48040BE3DBQ33621133-9FC0D560-B0A4-4B2B-8582-540FA1BEF862Q33662199-7BC5A6D3-DABB-4111-8F3D-551AB4270AD0Q34290839-4EE3474F-8752-4615-A2C0-32BF75C09DB1Q34804429-20F85928-4D93-490B-B795-12A96F12C7EDQ35130524-706AC7B1-7501-40C0-AEC5-28532D7FDE86Q35251912-C2DEDEE3-6D21-45C7-8A52-642F77EB179CQ35832816-694664FE-0D94-4941-9AB4-E8C6EC37FFD6Q36366153-F40BFCC0-CFEB-4D36-9298-98726EB1566BQ36508933-E4A9D8B7-287A-46FB-A690-6918A010C52DQ36758594-A3A9F33C-5991-4624-B7F4-F83F17F3C30FQ36913144-CDCC245B-9037-4E5A-9B02-329DD54F24F2Q37088914-0DD60D87-7920-45A5-BB7A-3ECF4F77D892Q37358849-494A386B-3424-4CD2-9D15-EC113680A434Q37589108-9D86FF61-C58D-443B-8DC5-3CF0B0C7B30BQ37671218-07490499-82BB-4D2F-8FE0-04517EB9B0AEQ38036102-5AA8081E-C267-4D52-A4E8-035C7F541825Q38206946-8F48FB90-8F1D-4DE6-9BC0-82E9563342A5Q38210478-46384F47-09FC-4112-9122-F4DBF3CFCD61Q38747640-B2D7F1F7-7DB7-4693-9F77-D3E6AB184E70Q38994767-6AAD5D42-9435-429A-9F36-98456B2FF237Q44071398-2B0CCC67-6260-425C-89F9-688A17F120D0Q47105156-D41D7423-1135-4258-9BC5-4AC5A5A2C01AQ47603739-4EAD3BBD-D3F1-4697-9B95-B33012E8DE53Q50193229-1E3A42D1-44E9-4B35-B5DC-0E9806120794Q52932746-FB71939E-0472-4B8F-9CC6-80CDD98CCAB6Q53019283-EA511BF2-6E32-4F52-9D5C-BCFE526B6C46
P2860
Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Autoimmunity to peptidyl argin ...... onset of rheumatoid arthritis.
@ast
Autoimmunity to peptidyl argin ...... onset of rheumatoid arthritis.
@en
Autoimmunity to peptidyl argin ...... onset of rheumatoid arthritis.
@nl
type
label
Autoimmunity to peptidyl argin ...... onset of rheumatoid arthritis.
@ast
Autoimmunity to peptidyl argin ...... onset of rheumatoid arthritis.
@en
Autoimmunity to peptidyl argin ...... onset of rheumatoid arthritis.
@nl
prefLabel
Autoimmunity to peptidyl argin ...... onset of rheumatoid arthritis.
@ast
Autoimmunity to peptidyl argin ...... onset of rheumatoid arthritis.
@en
Autoimmunity to peptidyl argin ...... onset of rheumatoid arthritis.
@nl
P2093
P2860
P356
P1476
Autoimmunity to peptidyl argin ...... onset of rheumatoid arthritis
@en
P2093
Antony Rosen
Colin I O'Donnell
Jason R Kolfenbach
Jess D Edison
Jill M Norris
Kevin D Deane
Lezlie A Derber
V Michael Holers
William R Gilliland
P2860
P304
P356
10.1002/ART.27570
P50
P577
2010-09-01T00:00:00Z